Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) VP Sells $4,473,456.00 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) VP Mark Elliott Boulding sold 85,600 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $52.26, for a total transaction of $4,473,456.00. Following the transaction, the vice president now owns 92,389 shares in the company, […]
More Stories
Pan American Silver (TSE:PAAS) Price Target Raised to C$45.00
Pan American Silver (TSE:PAAS – Get Free Report) had its price objective lifted by equities researchers at National Bankshares from...
Brookfield Renewable Partners (NYSE:BEP) Given New $40.00 Price Target at CIBC
Brookfield Renewable Partners (NYSE:BEP – Get Free Report) (TSE:BEP) had its target price increased by equities researchers at CIBC from...
Stock Analysts’ Price Target Changes for January 9th (ALA, ATZ, AYA, AYI, BEP, BNS, CXB, EDV, ENB, GBX)
Stock Analysts’ price target changes for Thursday, January 9th: AltaGas (TSE:ALA) had its price target increased by CIBC from C$40.00...
FDA Mandates Nerve Damage Warnings for 2 RSV Vaccines
By Naveen Athrappully The U.S. Food and Drug Administration (FDA) ordered two respiratory syncytial virus (RSV) vaccine manufacturers to include...
Rep. Virginia Foxx Sells Off Shares of Energy Transfer LP (NYSE:ET)
Representative Virginia Foxx (R-North Carolina) recently sold shares of Energy Transfer LP (NYSE:ET). In a filing disclosed on January 06th,...
Anterix (NASDAQ:ATEX) Reaches New 12-Month Low – Should You Sell?
Anterix Inc. (NASDAQ:ATEX – Get Free Report) reached a new 52-week low on Tuesday . The stock traded as low...